Free Trial

Clarivate (CLVT) Competitors

Clarivate logo
$4.46 -0.05 (-1.11%)
Closing price 03:59 PM Eastern
Extended Trading
$4.50 +0.04 (+1.01%)
As of 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CLVT vs. MEDP, HQY, BILI, WPP, LYFT, ETSY, AMTM, MARA, SEZL, and WSC

Should you be buying Clarivate stock or one of its competitors? The main competitors of Clarivate include Medpace (MEDP), HealthEquity (HQY), Bilibili (BILI), WPP (WPP), Lyft (LYFT), Etsy (ETSY), Amentum (AMTM), Marathon Digital (MARA), Sezzle (SEZL), and WillScot (WSC). These companies are all part of the "business services" industry.

Clarivate vs. Its Competitors

Medpace (NASDAQ:MEDP) and Clarivate (NYSE:CLVT) are both mid-cap business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability.

Medpace has a net margin of 19.31% compared to Clarivate's net margin of -26.32%. Medpace's return on equity of 54.36% beat Clarivate's return on equity.

Company Net Margins Return on Equity Return on Assets
Medpace19.31% 54.36% 20.81%
Clarivate -26.32%8.75%3.96%

Medpace currently has a consensus target price of $344.82, indicating a potential upside of 5.76%. Clarivate has a consensus target price of $5.00, indicating a potential upside of 12.11%. Given Clarivate's higher possible upside, analysts plainly believe Clarivate is more favorable than Medpace.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Medpace
0 Sell rating(s)
11 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.21
Clarivate
1 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67

Medpace has higher earnings, but lower revenue than Clarivate. Clarivate is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medpace$2.11B4.44$404.39M$13.1024.89
Clarivate$2.56B1.19-$636.70M-$0.97-4.60

78.0% of Medpace shares are held by institutional investors. Comparatively, 85.7% of Clarivate shares are held by institutional investors. 20.3% of Medpace shares are held by insiders. Comparatively, 23.2% of Clarivate shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Medpace has a beta of 1.47, meaning that its stock price is 47% more volatile than the S&P 500. Comparatively, Clarivate has a beta of 1.47, meaning that its stock price is 47% more volatile than the S&P 500.

In the previous week, Medpace and Medpace both had 6 articles in the media. Medpace's average media sentiment score of 0.82 beat Clarivate's score of 0.74 indicating that Medpace is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Medpace
3 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Clarivate
3 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Medpace beats Clarivate on 10 of the 14 factors compared between the two stocks.

Get Clarivate News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLVT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CLVT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CLVT vs. The Competition

MetricClarivateIT Services IndustryComputer SectorNYSE Exchange
Market Cap$3.08B$17.58B$27.19B$20.53B
Dividend YieldN/A1.48%3.15%3.77%
P/E Ratio-4.6039.1336.0427.85
Price / Sales1.1912.742,037.6937.49
Price / Cash2.6925.8737.6521.91
Price / Book0.624.987.054.55
Net Income-$636.70M$434.18M$763.02M$984.95M
7 Day Performance7.21%5.07%3.10%3.58%
1 Month Performance6.70%3.67%6.51%6.04%
1 Year Performance-20.00%30.28%52,212.28%14.49%

Clarivate Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CLVT
Clarivate
2.0409 of 5 stars
$4.46
-1.1%
$5.00
+12.1%
-18.7%$3.08B$2.56B-4.6012,000Insider Trade
MEDP
Medpace
4.4563 of 5 stars
$308.64
-0.2%
$349.30
+13.2%
-21.2%$8.89B$2.11B23.615,900
HQY
HealthEquity
3.6118 of 5 stars
$101.21
-0.1%
$118.09
+16.7%
+18.8%$8.76B$1.20B38.373,120
BILI
Bilibili
2.1343 of 5 stars
$19.91
+0.9%
$21.62
+8.6%
+39.6%$8.25B$3.68B0.008,088
WPP
WPP
0.938 of 5 stars
$35.50
+1.3%
N/A-21.2%$7.66B$18.84B5.95108,044
LYFT
Lyft
3.8798 of 5 stars
$14.95
+2.9%
$16.40
+9.7%
+15.9%$6.07B$5.79B69.192,934Trending News
ETSY
Etsy
3.6468 of 5 stars
$53.92
-4.0%
$49.87
-7.5%
-9.9%$5.86B$2.81B23.902,400Analyst Forecast
AMTM
Amentum
2.2776 of 5 stars
$21.94
+0.5%
$25.22
+15.0%
N/A$5.31B$8.39B0.0053,000
MARA
Marathon Digital
1.8582 of 5 stars
$14.18
-1.0%
$20.94
+47.7%
-30.4%$5.04B$656.38M65.099Options Volume
SEZL
Sezzle
2.2463 of 5 stars
$144.98
-1.4%
$96.94
-33.1%
+1,030.4%$4.89B$271.13M56.99540Analyst Forecast
Insider Trade
WSC
WillScot
4.3476 of 5 stars
$26.72
+1.9%
$40.63
+52.0%
-23.9%$4.87B$2.40B296.924,500

Related Companies and Tools


This page (NYSE:CLVT) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners